Quantification of extracellular volume with cardiac computed tomography in patients with dilated cardiomyopathy

Baggiano, Andrea; Conte, Edoardo; Spiritigliozzi, Luigi; Mushtaq, Saima; Annoni, Andrea; Carerj, Maria Ludovica; Cilia, Francesco; Fazzari, Fabio; Formenti, Alberto; Frappampina, Antonio; Fusini, Laura; Asinelli, Margherita Gaudenzi; Junod, Daniele; Mancini, Maria Elisabetta; Mantegazza, Valentina; Maragna, Riccardo; Marchetti, Francesca; Penso, Marco; Tassetti, Luigi; Volpe, Alessandra; Baessato, Francesca; Guglielmo, Marco; Rossi, Alexia; Rovera, Chiara; Andreini, Daniele; Rabbat, Mark; Guaricci, Andrea Igoren; Pepi, Mauro; Pontone, Gianluca

doi:10.1016/j.jcct.2023.04.005

Cited by 8 publications

(3 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…ECV assessed on CT has a good inter-observer reproducibility [50][51][52][53][54][55] and a good correlation to ECV measured on CMR in patients with valve disease and different cardiomyopathies [51][52][53][54][55][56][57][58][59]. CT-derived ECV was significantly higher in patients with heart failure with a preserved ejection fraction, ischemic, and non-ischemic cardiomyopathy than in controls [60][61][62][63].…”

Section: Extracellular Volumementioning

confidence: 88%

Cardiac CT in CRT as a Singular Imaging Modality for Diagnosis and Patient-Tailored Management

Gerrits,

Danad,

Velthuis

et al. 2023

JCM

Self Cite

View full text Add to dashboard Cite

Between 30–40% of patients with cardiac resynchronization therapy (CRT) do not show an improvement in left ventricular (LV) function. It is generally known that patient selection, LV lead implantation location, and device timing optimization are the three main factors that determine CRT response. Research has shown that image-guided CRT placement, which takes into account both anatomical and functional cardiac properties, positively affects the CRT response rate. In current clinical practice, a multimodality imaging approach comprised of echocardiography, cardiac magnetic resonance imaging, or nuclear medicine imaging is used to capture these features. However, with cardiac computed tomography (CT), one has an all-in-one acquisition method for both patient selection and the division of a patient-tailored, image-guided CRT placement strategy. This review discusses the applicability of CT in CRT patient identification, selection, and guided placement, offering insights into potential advancements in optimizing CRT outcomes.

show abstract

Section: Extracellular Volumementioning

confidence: 88%

Cardiac CT in CRT as a Singular Imaging Modality for Diagnosis and Patient-Tailored Management

Gerrits,

Danad,

Velthuis

et al. 2023

JCM

Self Cite

View full text Add to dashboard Cite

show abstract

“…Additionally, the estimation of ECV using a single-source, single-energy CT scanner for the entire heart has proven to be both feasible and accurate. This integration of ECV measurement into a comprehensive CCT evaluation for individuals newly diagnosed with dilated cardiomyopathy can be accomplished with only a marginal rise in overall radiation exposure [49].…”

Section: Role Of Cardiac Computed Tomography In Ahfmentioning

confidence: 99%

Multimodality Imaging in Advanced Heart Failure for Diagnosis, Management and Follow-Up: A Comprehensive Review

Pergola,

Cameli,

Mattesi

et al. 2023

JCM

Self Cite

View full text Add to dashboard Cite

Advanced heart failure (AHF) presents a complex landscape with challenges spanning diagnosis, management, and patient outcomes. In response, the integration of multimodality imaging techniques has emerged as a pivotal approach. This comprehensive review delves into the profound significance of these imaging strategies within AHF scenarios. Multimodality imaging, encompassing echocardiography, cardiac magnetic resonance imaging (CMR), nuclear imaging and cardiac computed tomography (CCT), stands as a cornerstone in the care of patients with both short- and long-term mechanical support devices. These techniques facilitate precise device selection, placement, and vigilant monitoring, ensuring patient safety and optimal device functionality. In the context of orthotopic cardiac transplant (OTC), the role of multimodality imaging remains indispensable. Echocardiography offers invaluable insights into allograft function and potential complications. Advanced methods, like speckle tracking echocardiography (STE), empower the detection of acute cell rejection. Nuclear imaging, CMR and CCT further enhance diagnostic precision, especially concerning allograft rejection and cardiac allograft vasculopathy. This comprehensive imaging approach goes beyond diagnosis, shaping treatment strategies and risk assessment. By harmonizing diverse imaging modalities, clinicians gain a panoramic understanding of each patient’s unique condition, facilitating well-informed decisions. The aim is to highlight the novelty and unique aspects of recently published papers in the field. Thus, this review underscores the irreplaceable role of multimodality imaging in elevating patient outcomes, refining treatment precision, and propelling advancements in the evolving landscape of advanced heart failure management.

show abstract

“…Imaging techniques have evolved over the years allowing a better understanding of these diseases [5,6]. For this reason a multimodal imaging approach, including ultrasound-based techniques, CMR imaging, computed tomography (CT), positron emission tomography (PET) and scintigraphy, is actually recommended in their diagnostic workup [2,[7][8][9]. Among all these techniques, CMR has become over the years the gold standard for non-invasive assessment of cardiac morphology, function, and myocardial tissue characterization [10][11][12].…”

Section: Introductionmentioning

confidence: 99%

The Role of Magnetic Resonance Imaging in Cardiomyopathies in the Light of New Guidelines: A Focus on Tissue Mapping

Forleo,

Carella,

Basile

et al. 2024

Preprint

View full text Add to dashboard Cite

Cardiomyopathies (CMPs) are a group of myocardial disorders that are characterized by structural and functional abnormalities of the heart muscle. These abnormalities occur in the absence of coronary artery disease (CAD), hypertension, valvular disease, and congenital heart disease. CMPs are an increasingly important topic in the field of cardiovascular diseases due to the complexity of their diagnosis and management. In 2023, the ESC guidelines on cardiomyopathies were first published, marking significant progress in the field. The growth of techniques such as cardiac magnetic resonance imaging (CMR) and genetics has been fueled by the development of multimodal imaging approaches. For the diagnosis of CMPs, a multimodal imaging approach, including CMR, is recommended. CMR has become the standard for non-invasive analysis of cardiac morphology and myocardial function. This document provides an overview of the role of CMR in CMPs, with a focus on tissue mapping. CMR enables the characterization of myocardial tissues and the assessment of cardiac functions. CMR sequences and techniques, such as late gadolinium enhancement (LGE) and parametric mapping, provide detailed information on tissue composition, fibrosis, edema, and myocardial perfusion. These techniques offer valuable insights for early diagnosis, prognostic evaluation, and therapeutic guidance of CMPs. The use of quantitative CMR markers enables personalized treatment plans, improving overall patient outcomes. This review aims to serve as a guide for the use of these new tools in clinical practice.

show abstract

Quantification of extracellular volume with cardiac computed tomography in patients with dilated cardiomyopathy

Cited by 8 publications

References 40 publications

Cardiac CT in CRT as a Singular Imaging Modality for Diagnosis and Patient-Tailored Management

Cardiac CT in CRT as a Singular Imaging Modality for Diagnosis and Patient-Tailored Management

Multimodality Imaging in Advanced Heart Failure for Diagnosis, Management and Follow-Up: A Comprehensive Review

The Role of Magnetic Resonance Imaging in Cardiomyopathies in the Light of New Guidelines: A Focus on Tissue Mapping

Contact Info

Product

Resources

About